---
input_text: Successful mismatched hematopoietic stem cell transplantation for pediatric
  hemoglobinopathy by using ATG and post-transplant cyclophosphamide. The use of HLA-mismatched
  (un)related donors is historically associated with a higher incidence of transplant-related
  complications and mortality. However, the use of such donors may overcome the limited
  availability of HLA-matched donors for patients with beta-thalassemia major (TM)
  and sickle cell disease (SCD). We investigated hematopoietic stem cell transplantation
  (HSCT) outcomes of pediatric TM and SCD patients treated with a mismatched donor
  using a treosulfan-based conditioning in combination with ATG and post-transplant
  cyclophosphamide (PT-CY) and compared these results to the clinical outcome of patients
  treated by matched donor HSCT without PT-CY. Thirty-eight children (n = 24 HLA-identical
  or 10/10-matched donors; n = 14 HLA-mismatched donors), who received a non-depleted
  bone marrow graft were included. Event-free survival (EFS) and GvHD were not higher
  in the mismatched PT-Cy group as compared to the matched group. Moreover, despite
  delayed neutrophil engraftment (day +22 vs. +26, p = 0.002) and immune recovery
  in the mismatched PT-Cy group, this did not result in more infectious complications.
  Therefore, we conclude that in the absence of an HLA-identical or a matched unrelated
  donor, HSCT with a mismatched unrelated or haploidentical donor in combination with
  ATG plus PT-CY can be considered a safe and effective treatment option for pediatric
  hemoglobinopathy patients.
raw_completion_output: |-
  primary_disease: pediatric hemoglobinopathy
  medical_actions: hematopoietic stem cell transplantation (HSCT);treosulfan-based conditioning;use of ATG;post-transplant cyclophosphamide (PT-CY)
  symptoms: transplant-related complications;mortality;delayed neutrophil engraftment;immune recovery delay;infectious complications
  chemicals: ATG;cyclophosphamide;treosulfan
  action_annotation_relationships: hematopoietic stem cell transplantation (HSCT) TREATS pediatric hemoglobinopathy IN pediatric hemoglobinopathy;treosulfan-based conditioning TREATS pediatric hemoglobinopathy IN pediatric hemoglobinopathy;use of ATG TREATS transplant-related complications;disease IN pediatric hemoglobinopathy;post-transplant cyclophosphamide (PT-CY) PREVENTS GvHD IN pediatric hemoglobinopathy;post-transplant cyclophosphamide (PT-CY) (with cyclophosphamide) TREATS transplant-related complications IN pediatric hemoglobinopathy
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  post-transplant cyclophosphamide (PT-CY) (with cyclophosphamide) TREATS transplant-related complications IN pediatric hemoglobinopathy

  ===

extracted_object:
  primary_disease: pediatric hemoglobinopathy
  medical_actions:
    - MAXO:0000747
    - treosulfan-based conditioning
    - use of ATG
    - post-transplant cyclophosphamide (PT-CY)
  symptoms:
    - transplant-related complications
    - mortality
    - delayed neutrophil engraftment
    - immune recovery delay
    - infectious complications
  chemicals:
    - ATG
    - CHEBI:4027
    - CHEBI:82557
  action_annotation_relationships:
    - subject: MAXO:0000747
      predicate: TREATS
      object: pediatric hemoglobinopathy
      qualifier: pediatric hemoglobinopathy
    - subject: conditioning
      predicate: TREATS
      object: hemoglobinopathy
      qualifier: pediatric hemoglobinopathy
      subject_qualifier: treosulfan-based
      object_qualifier: Pediatric
      subject_extension: CHEBI:82557
      object_extension: pediatric
    - subject: use of ATG
      predicate: TREATS
      object: transplant-related complications
    - subject: <post-transplant cyclophosphamide>
      predicate: <PREVENTS>
      object: <GvHD>
      qualifier: <pediatric hemoglobinopathy>
      subject_qualifier: <PT-CY>
      subject_extension: <cyclophosphamide>
    - subject: post-transplant cyclophosphamide (PT-CY) therapy
      predicate: TREATS
      object: transplant-related complications
      qualifier: pediatric hemoglobinopathy
      subject_qualifier: with cyclophosphamide
      subject_extension: CHEBI:4027
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MAXO:0010203
    label: echocardiography
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: HP:0001394
    label: Cirrhosis
  - id: HP:0002204
    label: Pulmonary embolus
  - id: HP:0001297
    label: Stroke
  - id: MONDO:0044348
    label: hemoglobinopathies
  - id: MONDO:0019740
    label: acquired thrombotic thrombocytopenic purpura (aTTP)
  - id: CHEBI:24261
    label: glucocorticoids
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: CHEBI:35480
    label: Analgesics
  - id: CHEBI:33281
    label: Antibiotics
  - id: CHEBI:35705
    label: immunosuppressive agents
  - id: MONDO:0002049
    label: Thrombocytopenia
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:47381
    label: Diclofenac
  - id: HP:0007018
    label: Attention deficits
  - id: CHEBI:6443
    label: levonorgestrel
  - id: HP:0001518
    label: Small for gestational age
  - id: HP:0001622
    label: Preterm
  - id: HP:0011105
    label: Fluid overload
  - id: HP:0001944
    label: dehydration
  - id: HP:0006775
    label: Multiple Myeloma
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0001903
    label: Anaemia
  - id: HP:0004421
    label: Elevated systolic blood pressures
  - id: CHEBI:33699
    label: mRNA
  - id: MAXO:0000068
    label: Transplantation
  - id: MAXO:0000149
    label: Evaluation for an allogeneic hematopoietic stem cell transplant (HCT)
  - id: CHEBI:50443
    label: normal hematopoietic stem cells (HSCs)
  - id: MAXO:0001001
    label: Gene therapies
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: MONDO:0005920
    label: Plasmodium falciparum malaria
  - id: HP:0001974
    label: Leukocytosis
  - id: HP:0001919
    label: Acute kidney injury
  - id: HP:0002140
    label: Ischemic stroke
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: CHEBI:30413
    label: Heme
  - id: CHEBI:35143
    label: Hemoglobin
  - id: MONDO:0006079
    label: Acute Chest Syndrome (ACS)
  - id: MAXO:0000955
    label: noninvasive, bi-level positive airway pressure ventilation (BiPAP)
  - id: HP:0012418
    label: hypoxemia
  - id: MONDO:0005632
    label: Acute Chest Syndrome
  - id: HP:0001649
    label: elevated heart rate
  - id: HP:0012531
    label: pain
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:125354
    label: Plerixafor
  - id: HP:0025085
    label: bloody stools
  - id: HP:0002027
    label: abdominal pain
  - id: MONDO:0100096
    label: covid-19
  - id: MAXO:0001017
    label: vaccination
  - id: MAXO:0000014
    label: radiotherapy
  - id: HP:0040319
    label: Dark urine
  - id: MONDO:0005136
    label: Malaria
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:51451
    label: endothelin receptor antagonists
  - id: MONDO:0020380
    label: sickle cell anemia (SCA)
  - id: CHEBI:49005
    label: deferasirox
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: CHEBI:9168
    label: Sirolimus
  - id: CHEBI:3770
    label: Trimethoprim/Sulfamethoxazole (TMP-SMX)
  - id: CHEBI:2453
    label: Acyclovir
  - id: HP:0040049
    label: macular oedema
  - id: CHEBI:18050
    label: l-glutamine
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000503
    label: mechanical ventilation
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia
  - id: CHEBI:17334
    label: Penicillin
  - id: MONDO:0003847
    label: Genetic Disorders
  - id: MAXO:0000573
    label: Assisted Reproductive Technology (ART)
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: MONDO:0019050
    label: hereditary hemoglobinopathies
  - id: MAXO:0000571
    label: Chronic transfusion (CT)
  - id: HP:0100699
    label: Scarring
  - id: HP:0002625
    label: Deep venous thrombosis (DVT)
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:6716
    label: depot medroxyprogesterone (DMPA)
  - id: CHEBI:59826
    label: progestin
  - id: MAXO:0000004
    label: Surgical intervention
  - id: HP:0200023
    label: Priapism
  - id: MAXO:0000011
    label: post-transplant (PT) cyclophosphamide
  - id: MAXO:0009065
    label: Intravenous push (IVP) analgesia
  - id: CHEBI:17303
    label: Morphine
  - id: MAXO:0000079
    label: Genetic counseling
  - id: MONDO:0009061
    label: Cystic fibrosis
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0000506
    label: Non-invasive ventilation
  - id: MAXO:0000586
    label: Invasive ventilation
  - id: MAXO:0000600
    label: Renal replacement therapy
  - id: MAXO:0000515
    label: Extracorporeal membrane oxygenation
  - id: HP:0100806
    label: Sepsis
  - id: HP:0002098
    label: respiratory distress
  - id: CHEBI:80240
    label: Endothelin-1
  - id: CHEBI:82557
    label: treosulfan
